These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32349271)

  • 1. Structure-Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist.
    Silva A; Xiao W; Wang Y; Wang W; Chang HW; Ames JB; Lam KS; Zhang Y
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.
    Wang Y; Xiao W; Zhang Y; Meza L; Tseng H; Takada Y; Ames JB; Lam KS
    Mol Cancer Ther; 2016 Feb; 15(2):232-40. PubMed ID: 26719578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
    Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
    ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.
    Xiang M; Lin Y; He G; Chen L; Yang M; Yang S; Mo Y
    J Mol Model; 2012 Nov; 18(11):4917-27. PubMed ID: 22736220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photocontrol of cell adhesion processes: model studies with cyclic azobenzene-RGD peptides.
    Schütt M; Krupka SS; Milbradt AG; Deindl S; Sinner EK; Oesterhelt D; Renner C; Moroder L
    Chem Biol; 2003 Jun; 10(6):487-90. PubMed ID: 12837381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin.
    Spitaleri A; Mari S; Curnis F; Traversari C; Longhi R; Bordignon C; Corti A; Rizzardi GP; Musco G
    J Biol Chem; 2008 Jul; 283(28):19757-68. PubMed ID: 18480047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.
    Liu S
    Bioconjug Chem; 2009 Dec; 20(12):2199-213. PubMed ID: 19719118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cilengitide-based cyclic RGD peptides as αvβ
    Meena CL; Singh D; Weinmüller M; Reichart F; Dangi A; Marelli UK; Zahler S; Sanjayan GJ
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127039. PubMed ID: 32094009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
    Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
    J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
    Choi Y; Kim E; Lee Y; Han MH; Kang IC
    Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics reveal that isoDGR-containing cyclopeptides are true αvβ3 antagonists unable to promote integrin allostery and activation.
    Ghitti M; Spitaleri A; Valentinis B; Mari S; Asperti C; Traversari C; Rizzardi GP; Musco G
    Angew Chem Int Ed Engl; 2012 Jul; 51(31):7702-5. PubMed ID: 22718573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
    Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
    J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
    Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
    J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
    Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
    Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.